Insurers point to Medicare Advantage as they boast about growth

Executives from several companies pointed to the program in their highlights as they discussed their upcoming year at the conference. (Getty/NicoElNino)

A common theme among insurers speaking at the J.P. Morgan Healthcare Conference this week: the boost from Medicare Advantage. Executives from several companies pointed to the program in their highlights as they discussed their upcoming year at the conference. 

Humana officials said they have been beating Wall Street expectations over the past several quarters in part because of their MA business. 

“[2019] is shaping up to be a very, very strong year,” said Chief Financial Officer Brian Kane. “We have revised upward our MA enrollment guidance. We expect individual MA growth this year to be 375,000 to 400,000 members. That’s a 12-13% growth rate. While we don’t have the CMS tape, which tells us how we did relative to the marketplace, our sense is that we’ll pick up meaningful share this year.” 


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

As part of its government line of business, Cigna’s CEO David Cordani said Cigna focuses on the individual MA business but sees the group MA business as well as “a future growth opportunity for us.” 

Medicare Advantage enrollment and spending are expected to surge over the next decade, until more than 4 in 10 beneficiaries are in the program by 2028, according to a recent report in the New England Journal of Medicine. The MA enrollment rate is set to grow from 34% in 2018 to 42% over the next 10 years.

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Policy changes are affecting how investors view the skilled home health market and paving the way for potential strategic acquisitions.